Header cover image

Chinese Pharmaceuticals & Biotech Buy the Dip

Results

1

1 new

Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.

1 companies

Pharmaron Beijing

Market Cap: CN¥78.5b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

New

300759

CN¥46.42

7D

-9.2%

1Y

52.1%